Transaction concentrates Elanco's focus on significant value creation opportunities and accelerates deleveraging progress GREENFIELD, Ind., July 9, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) announced today it has completed the divestiture of its aqua business to Merck Animal Health (NYSE: MRK) for approximately $1.3 billion in cash, with approximately $1.05-$1.1 billion in net proceeds available for debt paydown in the third quarter of 2024."Finalizing this transaction marks a sign ...